Freeline Therapeutics Company

Freeline Therapeutics is a biopharmaceutical company that develops liver directed gene therapies for bleeding disorders and other diseases. Its therapies are based on next-generation proprietary AAV vector platform, with its lead program being a gene therapy to treat haemophilia B.
Freeline Therapeutics was founded in 2015 and is headquartered in London, England.
Technology: Gene therapy
Industry: Personalized Medicine
Headquarters: Stevenage, Herefordshire, United Kingdom
Founded Date: 2015
Employees Number: 11-50
Funding Status: Early Stage Venture

Visit Website
Register and Claim Ownership